Figure 1

Purinergic profile of CAD patients and controls. (A) Adenosine plasma concentration (APC) in basal conditions, at the end of EST and after a 10-min recovery period was measured in 17 CAD patients and 17 controls (*: P < 0.01 compared with basal state). (B) A_2A receptor expression was evaluated using Western blotting in 17 controls and 17 CAD patients (*: P < 0.01). Data (AU) are expressed as mean, median and IQR. (C) Western blot analysis of A_2AR expression in a representative sample close to the mean value of each group of interest (Controls, EST−/EST+ patients) are shown.